2-Amino-5,5-dimethyl-5,6-dihydro-4H-benzothiazol-7-one, 95.0%, 5g

(R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHANOL, 95.0%, 25g

2-Bromo-N-methylbenzenesulfonamide, 95.0%, 1g

5-Oxononanedioic acid, 97%, 250mg

Preparation folder ROTILABO® plastic protected against light 1 piece

8,9,10,11-Tetrachloro-12H-isoindolo[2,1-a]perimidin-12-one, 95.0%, 100g

Lithium 2-(6-(1H-imidazol-1-yl)pyridazine-3-carboxamido)-4,5-difluorobenzoate, 98.0%, 250mg

Methyl 2-amino-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 1g

Methyl 2,5-Dichloronicotinate>98.0%(GC)200mg

3-carboethoxy-4'-piperidinomethyl benzophenone, 97.0%, 1g

Ethyl 4-Hydroxybenzoate>99.0%(GC)(T)500g

1-(3-(TERT-BUTYL)-1-PHENYL-1H-PYRAZOL-5-YL)-3-(2-FLUORO-4-((3-OXO-3,4-DIHYDROPYRIDO[2,3-B]PYRAZIN-8-YL)OXY)PHENYL)UREA, 97%, 10mg

4-(4-BROMOPHENYL)THIAZOLE-2-CARBOXYLIC ACID, 95.0%, 1g